<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>U&E / Electrolytes Guide</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="stylesheet" href="/genralPages.css">
  <script src="https://kit.fontawesome.com/834304401a.js" crossorigin="anonymous"></script>
  <script src="/script.js"></script>
  <style>
    body {
      font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;
      font-size: 16px;
      font-weight: bold;
      line-height: 1.6;
      color: #333;
      background-image: url("/images/bloodTestGuides.svg");
      background-size: cover;
      background-repeat: no-repeat;
      background-position: center;
    }

    main {
      max-width: 1000px;
      margin: 1.5rem auto;
      padding: 1rem;
      background: rgba(255, 255, 255, 0.94);
      border-radius: 10px;
    }

    h1.main-header {
      font-size: 1.6rem;
    }

    h2.subheading {
      font-size: 1.2rem;
      margin-top: 1.5rem;
      margin-bottom: 0.5rem;
      color: #003366;
      text-decoration: underline;
    }

    p {
      font-weight: normal;
      margin-bottom: 0.5rem;
    }

    .inline-note {
      font-size: 0.85rem;
      font-style: italic;
      color: #444;
      margin-bottom: 0.75rem;
    }

    .table-wrapper {
      width: 100%;
      overflow-x: auto;
      margin-bottom: 1.5rem;
      -webkit-overflow-scrolling: touch;
    }

    table {
      border-collapse: collapse;
      width: 100%;
      min-width: 650px; /* forces horizontal scroll on very small screens */
      margin-bottom: 0;
      font-weight: normal;
    }

    th, td {
      border: 1px solid #ccc;
      text-align: left;
      padding: 8px;
      vertical-align: top;
    }

    th {
      background-color: navy;
      color: whitesmoke;
      font-weight: 600;
      font-size: 0.9rem;
    }

    tr:nth-child(even) {
      background-color: #f2f2f2;
    }

    .param-name {
      font-weight: 600;
    }

    .tag {
      display: inline-block;
      padding: 0.1rem 0.4rem;
      border-radius: 4px;
      font-size: 0.75rem;
      font-weight: 600;
      margin-left: 0.25rem;
    }

    .tag-red {
      background: #b71c1c;
      color: #fff;
    }

    .tag-blue {
      background: #1565c0;
      color: #fff;
    }

    .tag-amber {
      background: #ffb300;
      color: #000;
    }

    .section {
      margin-bottom: 1.5rem;
    }

    .small-text {
      font-size: 0.85rem;
      color: #555;
    }

    @media (max-width: 600px) {
      main {
        margin: 0.75rem;
        padding: 0.75rem;
      }

      h1.main-header {
        font-size: 1.35rem;
      }

      h2.subheading {
        font-size: 1.05rem;
      }
    }
  </style>
</head>
<body>
  <header>
    <div class="logo-container">
      <h1 class="main-header">U&amp;E / Electrolytes &amp; Renal Guide</h1>
      <a href="/index.html" title="Home"><i class="fa-solid fa-house"></i></a>
      <button class="back-button" onclick="goBack()">Back</button>
    </div>
  </header>

  <main>
    <section class="section">
      <h2 class="subheading">How to Use This Page</h2>
      <p class="inline-note">
        Use this as a quick guide for interpreting U&amp;Es and related electrolytes at the bedside.
        Always interpret results with the clinical picture and local lab reference ranges.
      </p>
    </section>

    <section class="section">
      <h2 class="subheading">Electrolytes &amp; Renal Panel (including Ca / Mg / Phosphate)</h2>
      <div class="table-wrapper">
        <table>
          <thead>
            <tr>
              <th>Parameter</th>
              <th>High Value</th>
              <th>Low Value</th>
              <th>Common Causes of High</th>
              <th>Common Causes of Low</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td class="param-name">Sodium (Na⁺)</td>
              <td>Hypernatremia</td>
              <td>Hyponatremia</td>
              <td>
                Dehydration, diabetes insipidus, osmotic diuresis,<br>
                excessive salt intake, hyperaldosteronism.
              </td>
              <td>
                SIADH, heart failure, liver cirrhosis, nephrotic syndrome,<br>
                excess free water, thiazides, adrenal insufficiency.
              </td>
            </tr>
            <tr>
              <td class="param-name">Potassium (K⁺)</td>
              <td>Hyperkalemia <span class="tag tag-red">ECG risk</span></td>
              <td>Hypokalemia <span class="tag tag-red">ECG risk</span></td>
              <td>
                Renal failure, ACEi/ARB, spironolactone, potassium supplements,<br>
                acidosis, cell lysis (rhabdo, tumour lysis), Addison's disease.
              </td>
              <td>
                Diuretics, vomiting/diarrhoea, insulin + glucose, β-agonists,<br>
                hyperaldosteronism, alkalosis, poor intake.
              </td>
            </tr>
            <tr>
              <td class="param-name">Chloride (Cl⁻)</td>
              <td>Hyperchloremia</td>
              <td>Hypochloremia</td>
              <td>
                Normal saline overload, dehydration, renal tubular acidosis,<br>
                diarrhoea, metabolic acidosis.
              </td>
              <td>
                Vomiting, gastric losses, diuretics, metabolic alkalosis,<br>
                heart failure.
              </td>
            </tr>
            <tr>
              <td class="param-name">Bicarbonate (HCO₃⁻)</td>
              <td>High HCO₃⁻</td>
              <td>Low HCO₃⁻</td>
              <td>
                Metabolic alkalosis (vomiting, diuretics), chronic CO₂ retention (COPD),<br>
                volume depletion with contraction alkalosis.
              </td>
              <td>
                Metabolic acidosis (DKA, sepsis, renal failure, lactic acidosis),<br>
                diarrhoea, renal tubular acidosis.
              </td>
            </tr>
            <tr>
              <td class="param-name">Urea / BUN</td>
              <td>Increased urea (BUN)</td>
              <td>Decreased urea</td>
              <td>
                Pre-renal azotaemia: dehydration, shock, GI bleed;<br>
                renal failure; high protein intake; catabolic states.
              </td>
              <td>
                Severe liver disease, low protein intake, overhydration,<br>
                late pregnancy.
              </td>
            </tr>
            <tr>
              <td class="param-name">Creatinine</td>
              <td>Increased creatinine</td>
              <td>Decreased creatinine</td>
              <td>
                Acute or chronic kidney disease, obstruction, nephrotoxins,<br>
                rhabdomyolysis, hypotension/shock.
              </td>
              <td>
                Low muscle mass (elderly, cachexia), pregnancy,<br>
                amputations, malnutrition.
              </td>
            </tr>
            <tr>
              <td class="param-name">Calcium (Ca²⁺)</td>
              <td>Hypercalcemia</td>
              <td>Hypocalcemia</td>
              <td>
                Primary hyperparathyroidism, malignancy (bone mets, myeloma, PTHrP),<br>
                vitamin D excess, thiazides, prolonged immobilisation.
              </td>
              <td>
                Hypoparathyroidism, vitamin D deficiency, chronic kidney disease,<br>
                pancreatitis, massive transfusion (citrate).
              </td>
            </tr>
            <tr>
              <td class="param-name">Magnesium (Mg²⁺)</td>
              <td>Hypermagnesemia</td>
              <td>Hypomagnesemia</td>
              <td>
                Renal failure, excess Mg-containing antacids/laxatives,<br>
                iatrogenic over-replacement.
              </td>
              <td>
                Malnutrition, alcoholism, chronic diarrhoea, diuretics,<br>
                diabetes, PPIs, burns.
              </td>
            </tr>
            <tr>
              <td class="param-name">Phosphate (PO₄³⁻)</td>
              <td>Hyperphosphatemia</td>
              <td>Hypophosphatemia</td>
              <td>
                Chronic kidney disease, tumour lysis, rhabdomyolysis,<br>
                hypoparathyroidism, vitamin D excess.
              </td>
              <td>
                Malnutrition/refeeding, alcoholism, DKA treatment,<br>
                hyperparathyroidism, diarrhoea, diuretics.
              </td>
            </tr>
          </tbody>
        </table>
      </div>
      <p class="small-text">
        <strong>Tip:</strong> Always look at trends, not single values, and correlate with the ABG, fluid balance,
        and ECG (especially for K⁺, Ca²⁺, Mg²⁺).
      </p>
    </section>

    <section class="section">
      <h2 class="subheading">Chronic Kidney Disease – GFR-Based Staging</h2>
      <p class="inline-note">
        Staging is based on estimated GFR (eGFR). Creatinine values below are rough guides and will vary with lab,
        muscle mass, sex, and age. Use your lab’s eGFR where available.
      </p>

      <div class="table-wrapper">
        <table>
          <thead>
            <tr>
              <th>Stage</th>
              <th>eGFR (ml/min/1.73 m²)</th>
              <th>Typical Description</th>
              <th>Approx. Creatinine (&micro;mol/L)</th>
              <th>Approx. Creatinine (mg/dL)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td>G1</td>
              <td>&gt; 90</td>
              <td>Normal or high GFR (with other markers of kidney damage)</td>
              <td>&lt; ~104</td>
              <td>&lt; ~1.2</td>
            </tr>
            <tr>
              <td>G2</td>
              <td>60–89</td>
              <td>Mildly decreased GFR</td>
              <td>~104–159</td>
              <td>~1.2–1.8</td>
            </tr>
            <tr>
              <td>G3a</td>
              <td>45–59</td>
              <td>Mild–moderate decrease</td>
              <td>~159–200</td>
              <td>~1.8–2.3</td>
            </tr>
            <tr>
              <td>G3b</td>
              <td>30–44</td>
              <td>Moderate–severe decrease</td>
              <td>~200–309</td>
              <td>~2.3–3.5</td>
            </tr>
            <tr>
              <td>G4</td>
              <td>15–29</td>
              <td>Severely decreased</td>
              <td>~309–440</td>
              <td>~3.5–5.0</td>
            </tr>
            <tr>
              <td>G5</td>
              <td>&lt; 15</td>
              <td>Kidney failure (end-stage)</td>
              <td>&gt; ~440</td>
              <td>&gt; ~5.0</td>
            </tr>
          </tbody>
        </table>
      </div>

      <p class="small-text">
        <strong>Practical ED use:</strong> Think “GFR &lt; 30” (G4–G5) as a red flag for: dose-adjustment or avoidance
        of renally-cleared drugs, risk of volume overload, and need for urgent senior/nephrology input.
      </p>
    </section>
  </main>
</body>
</html>
